These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 29016442

  • 1. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report.
    Law GW, Yeo NEM, Howe TS, Tan YZ, Tan SB, Siddiqui MMA.
    Spine (Phila Pa 1976); 2018 May 01; 43(9):E551-E556. PubMed ID: 29016442
    [Abstract] [Full Text] [Related]

  • 2. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 01; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 3. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 01; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 4. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV, Blay JY, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S.
    Spine (Phila Pa 1976); 2021 Mar 01; 46(5):277-284. PubMed ID: 33038190
    [Abstract] [Full Text] [Related]

  • 5. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R.
    Eur J Surg Oncol; 2018 Sep 01; 44(9):1384-1390. PubMed ID: 29650420
    [Abstract] [Full Text] [Related]

  • 6. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS.
    Clin Orthop Relat Res; 2020 Nov 01; 478(11):2522-2533. PubMed ID: 32401001
    [Abstract] [Full Text] [Related]

  • 7. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW.
    JBJS Case Connect; 2016 Nov 01; 6(3):e74. PubMed ID: 29252651
    [Abstract] [Full Text] [Related]

  • 8. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.
    Lipplaa A, Dijkstra S, Gelderblom H.
    Curr Opin Oncol; 2019 Jul 01; 31(4):329-335. PubMed ID: 30844887
    [Abstract] [Full Text] [Related]

  • 9. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA.
    Clin Orthop Relat Res; 2018 Sep 01; 476(9):1783-1790. PubMed ID: 30778015
    [Abstract] [Full Text] [Related]

  • 10. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K, Suehara Y, Okubo T, Sasa K, Kurihara T, Akaike K, Kubota D, Torigoe T, Hasegawa N, Ishii M, Nakamura Y, Kim Y, Takagi T, Kaneko K, Hayashi T, Saito T.
    J Orthop Surg (Hong Kong); 2020 Sep 01; 28(2):2309499020929786. PubMed ID: 32539628
    [Abstract] [Full Text] [Related]

  • 11. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
    Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393
    [Abstract] [Full Text] [Related]

  • 12. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 01; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 13. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC.
    Orthop Surg; 2019 Dec 01; 11(6):1101-1108. PubMed ID: 31762217
    [Abstract] [Full Text] [Related]

  • 14. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
    Arefpour A, Shafieesabet M, Chehrassan M, Ahmadzadehnanva A, Ghandhari H.
    Musculoskelet Surg; 2024 Mar 01; 108(1):93-98. PubMed ID: 37940782
    [Abstract] [Full Text] [Related]

  • 15. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
    Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E.
    Lancet Oncol; 2019 Dec 01; 20(12):1719-1729. PubMed ID: 31704134
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.
    World J Surg Oncol; 2018 Aug 08; 16(1):160. PubMed ID: 30089488
    [Abstract] [Full Text] [Related]

  • 17. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F, Coutinho L, Fleming C, Magalhães M, Oliveira V, Rodrigues-Pinto R, Cardoso P.
    Eur J Orthop Surg Traumatol; 2020 Jan 08; 30(1):19-23. PubMed ID: 31529151
    [Abstract] [Full Text] [Related]

  • 18. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 19. Primary thoracic giant cell tumor of bone sensitive to steroids.
    Yang H, Im GH, Nielsen GP, Kheterpal A, Schwab JH.
    Skeletal Radiol; 2018 Oct 05; 47(10):1431-1435. PubMed ID: 29502130
    [Abstract] [Full Text] [Related]

  • 20. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 05; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.